1.Ostial Coronary Stenosis and Severe Aortic Stenosis in a Patient With Familial Hypercholesterolemia.
Hasan KAYA ; Faruk ERTAS ; Zuhal Ariturk ATILGAN ; Sinan DEMIRTAS ; Ahmet CALISKAN
Korean Circulation Journal 2012;42(8):580-581
No abstract available.
Aortic Valve Stenosis
;
Coronary Stenosis
;
Humans
;
Hyperlipoproteinemia Type II
2.Bilateral origin of superior cerebellar arteries from the posterior cerebral arteries, and clues to its embryologic basis.
Mennan Ece AYDIN ; Ahmet Hilmi KAYA ; Cem KOPUZ ; Mehmet Tevfik DEMIR ; Ufuk CORUMLU ; Adnan DAGCINAR
Anatomy & Cell Biology 2011;44(2):164-167
The superior cerebellar artery is the most consistent branch of the basilar artery and arises near the bifurcation of the basilar artery. A bilateral origin of the superior cerebellar arteries from the posterior cerebral arteries has been rarely reported in the literature. Reporting variations in brain vessels is important for neurosurgeons to safely and confidently treat pathologies in this region. We report on a specimen with a bilateral origin to the superior cerebellar artery from the posterior cerebral artery and discuss the embryogenesis of this rare variation.
Arteries
;
Basilar Artery
;
Brain
;
Embryonic Development
;
Female
;
Posterior Cerebral Artery
;
Pregnancy
3.The Impact of Trimetazidine Treatment on Left Ventricular Functions and Plasma Brain Natriuretic Peptide Levels in Patients with Non-ST Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Selami DEMIRELLI ; Sule KARAKELLEOGLU ; Fuat GUNDOGDU ; Muhammed Hakan TAS ; Ahmet KAYA ; Hakan DUMAN ; Husnu DEGIRMENCI ; Hikmet HAMUR ; Ziya SIMSEK
Korean Circulation Journal 2013;43(7):462-467
BACKGROUND AND OBJECTIVES: The aim of this study was to investigate the impact of treatment with oral trimetazidine (TMZ) applied before and after percutaneous coronary interventions (PCI) on short-term left ventricular functions and plasma brain natriuretic peptide (BNP) levels in patients with non-ST segment elevation myocardial infarction (NSTEMI) undergoing PCI. SUBJECTS AND METHODS: The study included 45 patients who were undergoing PCI with the diagnosis of NSTEMI. The patients were randomized into two groups. The first group (n=22) of the patients hospitalized with the diagnosis of NSTEMI was given conventional therapy plus 60 mg TMZ just prior to PCI. Treatment with TMZ was continued for one month after the procedure. TMZ treatment was not given to the second group (n=23). Echocardiography images were recorded and plasma BNP levels were measured just prior to the PCI and on the 1st and 30th days after PCI. RESULTS: The myocardial performance index (MPI) was greater in the second group (p=0.02). In the comparison of BNP levels, they significantly decreased in both of the groups during the 30-day follow-up period (29.0+/-8 and 50.6+/-33, p<0.01 respectively). However, decreasing of BNP levels was higher in the group administered with TMZ. The decrease of left ventriclular end-diastolic volume was observed in all groups at 30 days after intervention, but was higher in the group administered with TMZ (p=0.01). CONCLUSION: Trimetazidine treatment commencing prior to PCI and continued after PCI in patients with NSTEMI provides improvements in MPI, left ventricular end diastolic volume and a decrease in BNP levels.
Brain
;
Echocardiography
;
Follow-Up Studies
;
Humans
;
Myocardial Infarction
;
Natriuretic Peptide, Brain
;
Percutaneous Coronary Intervention
;
Plasma
;
Stroke Volume
;
Trimetazidine
;
Ventricular Function, Left
4.Association between the neutrophil-to-lymphocyte ratio, a new marker of systemic inflammation, and restless legs syndrome.
Ceyhun VARIM ; Bilgehan Atılgan ACAR ; Mehmet Sevki UYANIK ; Turkan ACAR ; Neslihan ALAGOZ ; Ahmet NALBANT ; Tezcan KAYA ; Hasan ERGENC
Singapore medical journal 2016;57(9):514-516
INTRODUCTIONRestless legs syndrome (RLS), also known as Willis-Ekbom disease, is characterised by abnormal sensations in the legs as well as dysaesthesia. Although the aetiology of RLS has not yet been determined, it may be associated with systemic inflammation. The neutrophil-to-lymphocyte ratio (NLR) is a new and simple marker indicating systemic inflammation. The present study aimed to investigate the relationship between systemic inflammation and RLS through the use of the NLR.
METHODSA total of 75 newly diagnosed patients with RLS and 56 healthy control subjects were included in the study. Baseline NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count. The NLRs of the two groups were compared.
RESULTSThere were no significant differences in gender and age between the two groups. The NLR was 1.96 ± 0.66 in the patient group and 1.67 ± 0.68 in the control group (p = 0.005). Receiver operating characteristic analysis was performed to determine the cut-off value of NLR to predict RLS. The NLR was predictive at 1.58 with a 64% sensitivity and 50% specificity (95% confidence interval 0.55-0.74, area under curve 0.648 ± 0.05). The NLR was found to be statistically higher in patients with RLS and may be used to predict RLS.
CONCLUSIONThe aetiology of RLS remains undetermined. The present study showed that systemic inflammation may play a role in RLS. However, RLS could also be associated with systemic inflammatory diseases. This relationship is supported by high NLR values, which are related to chronic systemic inflammation.
Adult ; Case-Control Studies ; Female ; Humans ; Inflammation ; Leukocyte Count ; Lymphocyte Count ; Lymphocytes ; cytology ; Male ; Middle Aged ; Neutrophils ; cytology ; ROC Curve ; Restless Legs Syndrome ; blood ; Surveys and Questionnaires